Literature DB >> 28153606

Herpesvirus DNA polymerases: Structures, functions and inhibitors.

Karima Zarrouk1, Jocelyne Piret1, Guy Boivin2.   

Abstract

Human herpesviruses are large double-stranded DNA viruses belonging to the Herpesviridae family. These viruses have the ability to establish lifelong latency into the host and to periodically reactivate. Primary infections and reactivations of herpesviruses cause a large spectrum of diseases and may lead to severe complications in immunocompromised patients. The viral DNA polymerase is a key enzyme in the lytic phase of the infection by herpesviruses. This review focuses on the structures and functions of viral DNA polymerases of herpes simplex virus (HSV) and human cytomegalovirus (HCMV). DNA polymerases of HSV (UL30) and HCMV (UL54) belong to B family DNA polymerases with which they share seven regions of homology numbered I to VII as well as a δ-region C which is homologous to DNA polymerases δ. These DNA polymerases are multi-functional enzymes exhibiting polymerase, 3'-5' exonuclease proofreading and ribonuclease H activities. Furthermore, UL30 and UL54 DNA polymerases form a complex with UL42 and UL44 processivity factors, respectively. The mechanisms involved in their polymerisation activity have been elucidated based on structural analyses of the DNA polymerase of bacteriophage RB69 crystallized under different conformations, i.e. the enzyme alone or in complex with DNA and with both DNA and incoming nucleotide. All antiviral agents currently used for the prevention or treatment of HSV and HCMV infections target the viral DNA polymerases. However, long-term administration of these antivirals may lead to the emergence of drug-resistant isolates harboring mutations in genes encoding viral enzymes that phosphorylate drugs (i.e., nucleoside analogues) and/or DNA polymerases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral agents; Antiviral drug resistance; DNA polymerase; DNA replication; Functions; Herpesviruses; Structure

Mesh:

Substances:

Year:  2017        PMID: 28153606     DOI: 10.1016/j.virusres.2017.01.019

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  25 in total

1.  Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.

Authors:  Karima Zarrouk; Van Dung Pham; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

2.  Amidate Prodrugs of Cyclic 9-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]adenine with Potent Anti-Herpesvirus Activity.

Authors:  Min Luo; Elisabetta Groaz; Steven De Jonghe; Robert Snoeck; Graciela Andrei; Piet Herdewijn
Journal:  ACS Med Chem Lett       Date:  2018-03-16       Impact factor: 4.345

3.  A3- and A2B-nitrocorroles: synthesis and antiviral activity evaluation against human cytomegalovirus infection.

Authors:  Léo Bucher; Sandrine Kappler-Gratias; Nicolas Desbois; Kerstin Bystricky; Franck Gallardo; Claude P Gros
Journal:  RSC Med Chem       Date:  2020-05-19

4.  A3- and A2B-fluorocorroles: synthesis, X-ray characterization and antiviral activity evaluation against human cytomegalovirus infection.

Authors:  Sandrine Kappler-Gratias; Léo Bucher; Nicolas Desbois; Yoann Rousselin; Kerstin Bystricky; Claude P Gros; Franck Gallardo
Journal:  RSC Med Chem       Date:  2020-07-13

5.  Host translesion polymerases are required for viral genome integrity.

Authors:  Sebastian Zeltzer; Pierce Longmire; Marek Svoboda; Giovanni Bosco; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-10       Impact factor: 12.779

6.  [Clinical effect of recombinant human interferon α1b adjuvant therapy in infectious mononucleosis: a prospective randomized controlled trial].

Authors:  Sha-Sha Dai; Kai Zhou
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

7.  Antiviral Drugs Against Herpesviruses.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.

Authors:  Karima Zarrouk; Xiaojun Zhu; Van Dung Pham; Nathalie Goyette; Jocelyne Piret; Rong Shi; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

9.  Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase.

Authors:  Robert P Hayes; Mee Ra Heo; Mark Mason; John Reid; Christine Burlein; Kira A Armacost; David M Tellers; Izzat Raheem; Anthony W Shaw; Edward Murray; Philip M McKenna; Pravien Abeywickrema; Sujata Sharma; Stephen M Soisson; Daniel Klein
Journal:  Nat Commun       Date:  2021-05-24       Impact factor: 14.919

10.  Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.

Authors:  Yuko Sato; Tadahiro Suenaga; Makoto Kobayashi; Nozomu Miyazaki; Takato Suzuki; Ken Ishioka; Tatsuo Suzutani
Journal:  Antimicrob Agents Chemother       Date:  2021-07-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.